Abstract:Objective:To monitor the concentration of mycophenolic acid (MPA) during six months after renal transplantation between Tacrolimus (FK506) and cyclosporine A (CsA) combined with mycophenolate mofetil (MMF), and observe the different MPA concentration and MMF dosage between two groups. Methodology:A total of 51 adult Chinese recipients of a primary cadaver kidney graft were randomly allocated in our renal transplant center. The patients were divided into FK506 (n=20) and CsA(n=31)combination group. MMF protocol is the same in two groups. The MPA concentration was evaluated with high-performance liquid chromatography, which was presented by the MPA area under the curve (MPA AUC 0-12). Within the first 6 months after transplantation, plasma samples for MPA AUC 0-12 were collected at 4 different timing (15day, 1 month, 3month, and 6 month). Results:The MPA AUC 0-12 of FK506 group was higher than that of CsA group during the early time [15th day: (56.0±21.1) vs (33.2±8.9)mg/L·h ,P<0.01, and 1st month: (54.0±12.5) vs (38.5±12.9) mg/L·h,P<0.01] with the same MMF dosage. The MPA AUC 0-12 and the MMF dosage had no difference between two groups in the 3~ rd and the 6~ th month. The average dosage of MMF in 3~ rd and 6~ th month for FK506 group was lower than that of CsA group( 3~ rd month:(1.10±0.29)g/d vs (1.27±0.25)g/d,P<0.05, 6~ th month:(1.02±0.18) vs (1.22±0.10)g/d,P<0.05) with the similar MPA AUC 0-12. There were no differences between two groups in body weight, hemoglobin, serum creatinine and albumin at four timing. Conclusion:The low dosage of MMF for Chinese people (in contrast to westerner) also can reach an effective MPA AUC 0-12. Combined with MMF, the MPA concentration of FK506 group was higher than that of CsA group within 1 month after transplantation with the same MMF dosage, and the MMF dosage of FK506 group was lower than that of CsA group from the third month with the same MPA concentration. Our data indicate that the MMF dosage should be adjusted individually in clinical practice.

Clinical Pharmacokinetics of Mycophenolic Acid of Recipients in the Early Period of Orthotopic Liver Transplantation

Pharmacokinetics of Mycophenolic Acid in Chinese Kidney Transplant Patients

Pharmacokinetics Study of Mycophenolate Mofetil in Renal Transplantation Patients

Cyclosporine A and Tacrolimus Combined with Enteric-Coated Mycophenolate Sodium Influence the Plasma Mycophenolic Acid Concentration - a Randomised Controlled Trial in Chinese Live Related Donor Kidney Transplant Recipients

Limited Sampling Strategy for Mycophenolic Acid in Chinese Kidney Transplant Recipients Receiving Enteric-Coated Mycophenolate Sodium and Tacrolimus During the Early Posttransplantation Phase

Short-Term Intensified Dosage Regimen of Mycophenolic Acid is Associated with Less Acute Rejection in Kidney Transplantation from Donation after Circulatory Death.

Pharmacokinetics Of Mycophenolic Acid In Chinese Patients With Liver Transplant (In Chinese) (Vol 41, Pg 1157, 2006)

Therapeutic Drug Monitoring of Mycophenolic Acid in Chinese Renal Allograft Recipients

Correlation Between Pharmacokinetics and Pharmacodynamics of Mycophenolic Acid in Liver Transplant Patients.

Investigation on Pharmacokinetics of Mycophenolic Acid in Chinese Adult Renal Transplant Patients.

Population Pharmacokinetics of Mycophenolic Acid in Renal Transplant Patients: A Comparison of the Early and Stable Posttransplant Stages

Monitoring mycophenolic acid pharmacokinetic parameters in liver transplant recipients: prediction of occurrence of leukopenia.

Limited Sampling Strategy for the Estimation of Mycophenolic Acid Area under the Plasma Concentration-Time Curve in Adult Patients Undergoing Liver Transplant.

Tacrolimus and cyclosporine A combined with mycophenolate mofetil influence on the plasma mycophenolic acid concentration

Clinical Mycophenolic Acid Monitoring In Liver Transplant Recipients

Relationship Between Pharmacokinetics and Pharmadynamics of Mycophenolic Acid in Liver Transplant Recipients

Population Pharmacokineties of Mycophenolic Acid in Chinese Adult Renal Transplant Patients

Evaluation of Mycophenolic Acid Exposure by Limited Sampling Strategy in Chinese Adult Renal Transplant Recipients Receiving Mycophenolate Mofeil and Tacrolimus

Pharmacokinetics of Mycophenolic Acid in Renal Transplant Patients after First-Dosing and in Steady-State

A Study on Monitoring of MPA Plasm Concentration of Chinese Kidney Transplantation Recipients

Influence of donor physiological condition on pharmacokinetics of mycophenolic acid and its metabolite in the early period after renal transplantation